ProMetic Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: axial	12/22/2016 4:37:14 PM
	of 250

PLASMINOGEN CORPORATE UPDATE VIDEO ' Please find below a link to a short corporate video where our President and Chief Executive Officer, Mr. Pierre Laurin, provides information on our plasma derived lead drug candidate, plasminogen, following the recent filing of the first module of the Biologics License Application with the FDA.Our plasminogen replacement therapy will be the first commercially available therapeutic product for patients with this congenital deficiency and we look forward to effectively bringing this to market later in 2017.' prometiclifesciencesinc.cmail19.com Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next